Health Catalyst Sees Q2 Adj. EBITDA Loss $4.8M-$2.8M, Sales $55.1M-$58.1M vs $54.8M Estimate; FY21 Adj. EBITDA Loss $15M-$13M, Sales $228.1M-$231.1M vs $227.9M Est.

Dark

Check out our Dark Pool Levels

Health Catalyst Sees Q2 Adj. EBITDA Loss $4.8M-$2.8M, Sales $55.1M-$58.1M vs $54.8M Estimate; FY21 Adj. EBITDA Loss $15M-$13M, Sales $228.1M-$231.1M vs $227.9M Est.

Benzinga | May 6, 2021 04:36PM EDT

Health Catalyst Sees Q2 Adj. EBITDA Loss $4.8M-$2.8M, Sales $55.1M-$58.1M vs $54.8M Estimate; FY21 Adj. EBITDA Loss $15M-$13M, Sales $228.1M-$231.1M vs $227.9M Est.

Share

Connect with us

© 2020 - 2026 ChartExchange LLC